A Clinical Trial To Study the Effects and Safety Of Two Drugs Minoxidil and Finasteride in Male Androgenic Alopecia
- Conditions
- Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- CTRI/2022/03/041364
- Lead Sponsor
- Krishna institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Male patient comes with history or clinical findings suggestive of androgenic alopecia.
2. Age group more than 18 years of age and less than 50 years of age
3. Hamilton grade 2-6
4. Have given written consent before investigation and starting the drug.
5. Be able and willing and fit , in the view of investigator , to comply all study procedures
1. Patient who is hypotensive or hypertensive
2. Patients with grade 1 or grade 7 alopecia.
3. Patient with cardiac diseases (including angina, coronary artery disease, recent or acute myocardial infarction, pericardial effusion)
4. Patients with cerebrovascular diseases
5. Patients with deranged liver and kidney function.
6. Patients allergic to finasteride or minoxidil.
7. Patient on any treatment for androgenic alopecia for last 2 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.average hair thickness improvement by more than 10 percent <br/ ><br>2.Increase in terminal vellus hair ratio.Timepoint: Baseline <br/ ><br>4 weeks <br/ ><br>8 weeks <br/ ><br>12 weeks <br/ ><br>16 weeks <br/ ><br>20 weeks <br/ ><br>24 weeks
- Secondary Outcome Measures
Name Time Method clinical photographyTimepoint: Baseline <br/ ><br>4 weeks <br/ ><br>8 weeks <br/ ><br>12 weeks <br/ ><br>16 weeks <br/ ><br>20 weeks <br/ ><br>24 weeks